These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32895522)

  • 1. A framework for designing delivery systems.
    Poon W; Kingston BR; Ouyang B; Ngo W; Chan WCW
    Nat Nanotechnol; 2020 Oct; 15(10):819-829. PubMed ID: 32895522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis.
    Posadas I; Monteagudo S; Ceña V
    Nanomedicine (Lond); 2016 Apr; 11(7):833-49. PubMed ID: 26980585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical and computational investigations of nanoparticle-biomembrane interactions in cellular delivery.
    Ding HM; Ma YQ
    Small; 2015 Mar; 11(9-10):1055-71. PubMed ID: 25387905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of interactions between nanoparticles and the immune system.
    Dobrovolskaia MA; Shurin M; Shvedova AA
    Toxicol Appl Pharmacol; 2016 May; 299():78-89. PubMed ID: 26739622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid Bilayers: Stability and Encapsulation of Nanoparticles.
    Alipour E; Halverson D; McWhirter S; Walker GC
    Annu Rev Phys Chem; 2017 May; 68():261-283. PubMed ID: 28301758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cover Story: Nanoparticle properties affecting nuclear targeting in cancer and normal cells.
    Park K
    J Control Release; 2017 May; 253():184. PubMed ID: 28601163
    [No Abstract]   [Full Text] [Related]  

  • 11. Nose-to-brain peptide delivery - The potential of nanotechnology.
    Samaridou E; Alonso MJ
    Bioorg Med Chem; 2018 Jun; 26(10):2888-2905. PubMed ID: 29170026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology for delivery of peptide nucleic acids (PNAs).
    Gupta A; Bahal R; Gupta M; Glazer PM; Saltzman WM
    J Control Release; 2016 Oct; 240():302-311. PubMed ID: 26776051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramolecular nanoscale assemblies for cancer diagnosis and therapy.
    Coelho SC; Pereira MC; Juzeniene A; Juzenas P; Coelho MAN
    J Control Release; 2015 Sep; 213():152-167. PubMed ID: 26160308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancement of nanoscience in development of conjugated drugs for enhanced disease prevention.
    Taneja P; Sharma S; Sinha VB; Yadav AK
    Life Sci; 2021 Mar; 268():118859. PubMed ID: 33358907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal nanoparticle design for effective transport through the blood-brain barrier.
    Park K
    J Control Release; 2019 Feb; 295():290. PubMed ID: 30704674
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of Cyclodextrins in Nanoparticle-Based Drug Delivery Systems.
    Shelley H; Babu RJ
    J Pharm Sci; 2018 Jul; 107(7):1741-1753. PubMed ID: 29625157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive models of nanoparticle transport in solid tumors.
    Park K
    J Control Release; 2014 Oct; 192():325. PubMed ID: 25236391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.